People are worried what will happen with data 23andMe collected after they announced they filled for bankruptcy. The post 23AndMe Goes Bankrupt, Netizens Are Concerned What’s Going To Happen To ...

23andMe, which helped popularize ancestry tracing through genetic testing, filed for bankruptcy protection and will seek a sale. Latest U.S.

The genetic testing company 23andMe — which allows users to spit in a tube and send away the sample for a detailed DNA analysis — is filing for bankruptcy. 23andMe has faced financial hardship ...

To delete data from 23andMe, customers should log in to their account and navigate to the “Settings” section of their profile. At the bottom of the page, click on “23andMe Data,” and then ...

That’s why he believes 23andMe’s bidders will most likely be interested in using the data for health and medical research. “Doctors (are) guessing. They’re following rules.

DNA testing pioneer 23andMe filed for bankruptcy — sparking fresh concerns about safeguarding the personal data of the company’s more than 15 million customers. The former Silicon Valle… ...

Genetic testing firm 23andMe is set to be acquired by drug company Regeneron Pharmaceuticals following its bankruptcy in March, the companies announced on Monday, May 19. Regeneron purchased the ...

23andMe and its co-founder, Anne Wojcicki, aimed to revolutionize healthcare. Earlier this year, WSJ took a look at factors that knocked the company’s valuation down to nearly $0. Photo: Peter ...

Your 23andMe data is getting a new owner — so what are your options moving forward? The DNA testing company announced on Monday that its assets are being acquired by Regeneron Pharmaceuticals.

Regeneron Pharmaceuticals is buying 23andMe out of bankruptcy for $256 million. REUTERS. The Tarrytown, New York-based pharmaceutical company pledged to remain compliant with 23andMe’s consumer ...

DNA-testing company 23andMe and its co-founder, Anne Wojcicki, aimed to revolutionize healthcare, bringing genetic tests into homes with just a tube of spit. WSJ takes a look at factors that ...

23andMe, the genetic testing company that was once valued at $6 billion but filed for bankruptcy in March, will be bought by Regeneron Pharmaceuticals, a biotechnology company that has used DNA ...